Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol alone versus misoprostol plus vaginal estrogen for induced abortion
IRCT20190208042655N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Induced Abortion (TOP) comparing Misoprostol alone with Misoprostol plus vaginal estrogen (2 arms). Primary endpoints: Successful abortion, Number of misoprostol doses used and 2 more. Started Apr 2022; status: completed.
02
Drugs
misoprostolestradiol
03
Conditions
Induced Abortion (TOP)
Beyond the preview
Go deeper on IRCT20190208042655N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190208042655N2.